DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria

NCT02450578 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Plasmodium Falciparum, Malaria

Interventions

DRUG: DSM265 400mg
DRUG: Placebo to DSM265 400 mg
BIOLOGICAL: Plasmodium falciparum sporozoite challenge
DRUG: Malarone

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]